Learn about the OM1 PremiOM Heart Failure Dataset and meet our cardiometabolic expert
Longitudinal patient journeys in heart failure
Tracking disease activity, lab results, imaging studies, comorbidities, treatments, and outcomes over time
*Counts complete through Q2 2024
OM1 Cardiology Data
Amyloidosis
Atrial Fibrillation
Cardiomyopathy
Hyperlipidemia
Ischemic Heart Disease
MASH*
Obesity
Peripheral Vascular Disease
Stroke
Tachycardia
*Formerly known as NASH
Demonstrate comparative effectiveness
Evaluate treatment response and utilization
Measure impact of comorbidities
Predict outcomes and events
And more
